Use of tociluzumab in the thrombocytopenic COVID-19 patient: A challenge in the therapeutic approach

Categoría del artículo: Letter to Editor

Publicado en línea: 29 dic 2022

Páginas: 89 - 90

DOI: https://doi.org/10.2478/rjaic-2021-0015

Palabras clave

© 2021 Ozlem Ozkan Kuscu and Pinar Ergenoglu, published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.